These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30035130)

  • 21. New era of regulatory T cells in tumor immunity: insights in cancer immunotherapy.
    Sheu BC; Chang WC; Huang SC
    J Formos Med Assoc; 2010 Jan; 109(1):1-3. PubMed ID: 20123581
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer.
    Toor SM; Elkord E
    Immunol Cell Biol; 2018 Oct; 96(9):888-897. PubMed ID: 29635843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Garrido F
    Cancer Immunol Immunother; 2012 May; 61(5):739-45. PubMed ID: 22350069
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer Immunotherapy: Theory and Application.
    Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
    J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy using regulatory T cells in cancer suggests more flavors of hypersensitivity type IV.
    Pakravan N; Hassan ZM
    Immunotherapy; 2018 Mar; 10(3):213-219. PubMed ID: 29370722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy and Vaccine Development.
    Leung C; Münz C; Riemer A
    J Immunol Res; 2018; 2018():8751027. PubMed ID: 30009188
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
    Fecek RJ; Storkus WJ
    Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative strategy for improving cancer immunotherapy.
    Cao X
    J Mol Med (Berl); 2016 May; 94(5):485-7. PubMed ID: 27114349
    [No Abstract]   [Full Text] [Related]  

  • 30. PD-1/PD-L1 in disease.
    Kuol N; Stojanovska L; Nurgali K; Apostolopoulos V
    Immunotherapy; 2018 Feb; 10(2):149-160. PubMed ID: 29260623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunosuppression by Treg can be decreased with anti-GARP antibodies].
    Lucas S
    Med Sci (Paris); 2015 Oct; 31(10):832-4. PubMed ID: 26481020
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination Immunotherapy: Taking Cancer Vaccines to the Next Level.
    Grenier JM; Yeung ST; Khanna KM
    Front Immunol; 2018; 9():610. PubMed ID: 29623082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 34. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insight into cancer immunotherapy.
    Escribese MM; Barber D
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():50-55. PubMed ID: 29108766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological tumor therapy].
    Dietrich K; Theobald M
    Internist (Berl); 2015 Aug; 56(8):907-16; quiz 917. PubMed ID: 26187335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can calcium signaling be harnessed for cancer immunotherapy?
    Rooke R
    Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conference scene: immune effector mechanisms in tumor immunity.
    Sikora AG; Hailemichael Y; Overwijk WW
    Immunotherapy; 2012 Feb; 4(2):141-3. PubMed ID: 22339456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
    Chang MC; Chen YL; Lin HW; Chiang YC; Chang CF; Hsieh SF; Chen CA; Sun WZ; Cheng WF
    Mol Ther; 2018 Feb; 26(2):404-419. PubMed ID: 29248428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer immunotherapy--revisited.
    Lesterhuis WJ; Haanen JB; Punt CJ
    Nat Rev Drug Discov; 2011 Aug; 10(8):591-600. PubMed ID: 21804596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.